Skip to main content
. 2019 Jun 20;9:8918. doi: 10.1038/s41598-019-45509-0

Figure 2.

Figure 2

Adiponectin/ACRP30 alleviates aberrant GSK3β and NF-κB signalling in the 5XFAD mouse hippocampus. (a) GSK3β activation and cleaved caspase 3 protein levels were increased in 5XFAD mouse hippocampus compared with those in wild-type mice; these were alleviated by adiponectin/ACRP30 treatment for 10 min and 2 h. (b) Phosphorylated p65 (p-p65) protein levels were significantly increased in 5XFAD mouse hippocampus compared with those in the control; this increase was suppressed by adiponectin/ACRP30 treatment for 10 min and 2 h. (c) Analysis of IL-1β, IL-6 and IL-10 expression by Western blotting (n = 4 in each group). Data are expressed as means ± SEMs. *p < 0.05, **p < 0.001, ***p < 0.0001; a.10 and a.2 indicate 2.7 nM adiponectin/ACRP30 treatment for 10 min and 2 h, respectively; C, 5XFAD control mouse hippocampus.